WCVI News & Announcements
January 2019: Shinobu Matssura DVM, PhD
January 29, 2019 1K010D025290-01A1 Shinobu Matsuura DVM, PhD Project Title: The Bone Marrow Extracellular Matrix: Scaffold of Hematopoiesis Project period: 02/01/2019 - 01/31/2024
November 2018: Alissa Frame
November 7, 2018 Congratulations to Alissa Frame (MD, PhD candidate, from the Wainford lab) ! She won the Third Place Basic Research Award in the 2018 Evans Department of Medicine Research Days, Oral Presentations Session on October 11, 2018. “Renal and Neural Mechanisms of Salt Sensitivity in Age-Related Hypertension”
October 2018: Richard Wainford, PhD
Grant announcement: 1R56AG057687-01A1 Contact PI / Project Leader: WAINFORD, RICHARD DAVID Title: AGING AND HYPERTENSION: INTEGRATED RENAL AND SYMPATHETIC CONTROL OF BLOOD PRESSURE Date 09/15/2018-8/31/2019
October 2018: Shakun Karki, PhD
Shakun Karki, PhD was promoted to Assistant Professor of Medicine.
October 2018: Rosa Breton Romero, PhD
Rosa Breton Romero, PhD was appointed an Instructor of Medicine
October 2018: Vijaya B. Kolachalama, PhD
October 4, 2018 The Kolachalama lab was recently featured in Nature Magazine. The article can be found with this link . Lab website link. Lab Twitter account link.
July 2018: Grant Announcements
July 1, 2019 Grant Number: K01DK114897-01A1 Principal Investigator: Shakun Karki, PhD Project Title: FSP27 regulation of vascular function in human obesity Project Period: 7/1/2018 – 6/30/2022
WCVI Pilot Grant Early Career Awardees Announced
Congratulations WCVI Pilot Grant Early Career Awardees for Summer 2018 July 1, 2018 - June 30, 2019 Rosa Breton-Romero, PhD; Postdoctoral Associate *Photo pending* Beatriz Ferran Perez, PhD; Postdoctoral Associate Jessica L. Fetterman, PhD Assistant Professor Vijaya B. Kolachalama, PhD; Assistant Professor Ivan Luptak, M.D. PhD; Assistant Professor María Valero-Muñoz, PhD; Postdoctoral Associate
June 2018: Flora Sam, MD
“A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study Evaluating the Safety and Efficacy of Different Doses of IW-1973 over 12 Weeks in Patients with Heart Failure with Preserved Ejection Fraction (CAPACITY HFpEF )” – Sponsor: Ironwood Pharmaceuticals, Inc. PI: Flora Sam, MD; funded 2018-2019
June 2018: Naomi Hamburg, MD
Naomi Hamburg, MD Installed as Joseph A. Vita, MD, Professor of Cardiovascular Medicine. See full article here.